Image
![DTG FAQ Screenshot](/sites/default/files/2017-10/Screenshot_73.jpg)
Topics:
Projects:
Authored on
Description
This fact sheet answers frequently asked questions about dolutegravir, a new antiretroviral available in generic form in low- and middle-income countries. Topics include transitioning to new treatment options, pricing and supply chain risks, among others.